Pazopanib or sunitinib for metastatic renal-cell carcinoma?

被引：0
作者：
Bennet, Neil
机构：
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 11期
关键词：
D O I：
10.1016/S1470-2045(13)70409-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E442 / E442
页数：1
相关论文
共 50 条
  • [31] Sunitinib for metastatic renal cell carcinoma
    Mukherji, Deborah
    Larkin, James
    Pickering, Lisa
    FUTURE ONCOLOGY, 2010, 6 (09) : 1377 - 1385
  • [32] To compare the efficacy and safety of pazopanib and sunitinib in metastatic renal cell carcinoma (RCC) of Chinese population
    Chan, M. F. T.
    Lam, Q. Y. N.
    Lee, V. H. F.
    Siu, S. W. K.
    Kwong, P. W. K.
    Leung, T. W.
    ANNALS OF ONCOLOGY, 2015, 26 : 77 - 77
  • [33] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Ruiz-Morales, Jose Manuel
    Swierkowski, Marcin
    Wells, J. Connor
    Fraccon, Anna Paola
    Pasini, Felice
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Sim, Hao-Wen
    Sliwczynsk, Andrzej
    Ptak-Chmielewska, Aneta
    Teter, Zbigniew
    Beuselinck, Benoit
    Wood, Lori A.
    Yuasa, Takeshi
    Pezaro, Carmel
    Rini, Brian I.
    Szczylik, Cezary
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN JOURNAL OF CANCER, 2016, 65 : 102 - 108
  • [34] Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
    Gore, Martin E.
    Szczylik, Cezary
    Porta, Camillo
    Bracarda, Sergio
    Bjarnason, Georg A.
    Oudard, Stephane
    Hariharan, Subramanian
    Lee, Se-Hoon
    Haanen, John
    Castellano, Daniel
    Vrdoljak, Eduard
    Schoffski, Patrick
    Mainwaring, Paul
    Nieto, Alejandra
    Yuan, Jinyu
    Bukowski, Ronald
    LANCET ONCOLOGY, 2009, 10 (08) : 757 - 763
  • [35] Pazopanib for the Treatment of Metastatic Renal Cell Carcinoma
    Pick, Amy M.
    Nystrom, Kelly K.
    CLINICAL THERAPEUTICS, 2012, 34 (03) : 511 - 520
  • [36] THE SIDE EFFECTS OF SORAFENIB, SUNITINIB, AND TEMSIROLIMUS AND THEIR THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    Bhojani, N.
    Jeldres, C.
    Patard, J. -J.
    Perrotte, P.
    Suardi, N.
    Hutterer, G.
    Patenaude, F.
    Oudard, S.
    Karakiewicz, P. I.
    ONKOUROLOGIYA, 2009, 5 (04): : 25 - 36
  • [37] Re: First-Line Sunitinib versus Pazopanib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Laguna, M. Pilar
    JOURNAL OF UROLOGY, 2017, 197 (03) : 603 - 603
  • [38] PROGNOSTIC IMPLICATIONS OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH PAZOPANIB AND SUNITINIB
    Raghunath, Ajay
    Murphy, Milo
    Zhang, Karen
    Parente, Phillip
    McKendrick, Joseph
    Davis, Ian
    Pezaro, Carmel
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 48 - 48
  • [39] RENAL-CELL CARCINOMA METASTATIC TO PENIS
    ORDONEZ, NG
    AYALA, AG
    BRACKEN, RB
    UROLOGY, 1982, 19 (04) : 417 - 419
  • [40] NEPHRECTOMY IN METASTATIC RENAL-CELL CARCINOMA
    FOWLER, JE
    UROLOGIC CLINICS OF NORTH AMERICA, 1987, 14 (04) : 749 - 756
12345